Claret Capital Closes €575M Fund IV to Back European Tech and Life Sciences

The raise brings Claret's total capital raised since it was founded to €1.3 billion. Since 2013, the firm has deployed more than €1.5 billion through its funds, supporting over 210 companies across the technology, life sciences and impact sectors.

Claret plans to invest Fund IV across Europe's technology and life sciences ecosystems. The firm provides growth debt, a form of financing that can help companies expand while limiting equity dilution. Loans typically range from €2 million to €100 million, with each opportunity individually assessed. Companies can use the capital for organic growth, acquisitions, research and development, capital expenditure, working capital, marketing and geographical expansion.

David Bateman, Managing Partner at Claret Capital Partners, said the raise validated the firm's approach and track record and represented a vote of confidence in Europe's technology, life sciences and impact ecosystems, adding that the team was actively deploying capital and seeking entrepreneurs building the next generation of European companies, according to EU-Startups.

AI Startups Draw Cross-Border Funding, From London Hiring Agents to Riyadh Procurement

Four AI-focused startups across the UK, Saudi Arabia, Lithuania and the US disclosed new funding rounds ranging from €1.7 million to $875 million.